Global Medical Device Regulation: Emphasis on Active Implants: Usfda, Emea and Anvisa - Bhuvan P. Raval - Grāmatas - LAP LAMBERT Academic Publishing - 9783659445736 - 2013. gada 16. augusts
Ja vāks un nosaukums nesakrīt, pareizs ir nosaukums

Global Medical Device Regulation: Emphasis on Active Implants: Usfda, Emea and Anvisa

Cena
€ 56,49

Pasūtīts no attālās noliktavas

Paredzamā piegāde . gada 10. - 18. sept.
Saņemiet paziņojumus par jauniem Bhuvan P. Raval izdevumiem
Pievienot savam iMusic vēlmju sarakstam

Not rated yet

Regulations for medical devices in EU Member countries are governed by European Medicine Evaluation Authority, popularly known as EMEA. As per EMEA's guideline each member country has to strictly follow the common guidelines with exception to rules and regulation that are modified by state authorities but must be in conformity with EMEA Guideline. Regulations posed in here are further divided in implantable and active implantable medical devices thereafter where manufacturing, testing and distribution can only be done once it is CE marked. In case of non CE marked devices i.e. non-EU member manufacturer, market authorisation process shall be completed prior to approval and separately. For brazil market that is governed by ANVISA, medical devices are classified into four different classes. There is no independent discrimination made for Active implantable medical devices but most non invasive devices are covered in Class I. While those which are to be connected with blood storage and other devices are classified into class II. Class III devices are those which are connected or included with wounds or healthy tissues.

Mediji Grāmatas     Paperback Book   (Grāmata ar mīksto vāku un līmēto muguru)
Izlaists 2013. gada 16. augusts
ISBN13 9783659445736
Izdevēji LAP LAMBERT Academic Publishing
Lapas 144
Izmēri 150 × 9 × 226 mm   ·   233 g
Valoda Vācu  

Vairāk no Bhuvan P. Raval

Rādīt visu